// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

It’s good to talk: significant cost savings associated with telephone delivered stock control for patients on Benepali

Jonathan L Marks - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Etanercept

Proteomic analysis of neutrophil extracellular traps in rheumatoid arthritis and systemic lupus erythematosus

Elinor A Chapman - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Arginine hydrochloride

NKX2-5 causes endothelial dysfunction in SSc-PAH

Jamil Santos Cade - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Vasodilation dysfunction

Casein

APPA inhibits neutrophil pro-inflammatory functions without impairing host defence: is this a potential new therapy for arthritis?

Andrew L Cross - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

GM-CSF

Targeting combined treatment to arthritic joints by antibody specific to damaged cartilage

Ahuva Nissim - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Systemic sclerosis fibroblasts show defective activation by coagulation factor XIII in vitro: implications for impaired wound healing in SSc

Anna Leslie - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

mitomycin

Gene expression profiling identifies classifier of methotrexate non-response in patients with rheumatoid arthritis

Darren Plant - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

Modulation of monocyte autophagy as a therapeutic target in antiphospholipid syndrome

Vera M Ripoll - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Antiphospholipid syndrome

N/A

Evidence for altered peroxisome proliferator activated receptor (PPAR) pathway activity in a transgenic mouse model of scleroderma (TbRIIDk-fib): analysis of mouse skin, lung and explanted cells

Emma Derrett-Smith - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Therapeutic glucocorticoids prevent local and systemic bone loss but exacerbate muscle wasting when administered in chronic inflammation

Chloe G Fenton - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Glucocorticoid

Both Domain I and PEGylated Domain I of Beta-2-Glycoprotein I (β2GPI) are capable of inhibiting IgA APS antibody binding

Aylin Albay - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Generation and validation of an in vitro model of Langhans-type multinucleated giant cells to investigate giant cell arteritis

Daniel Maunder - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

GM-CSF

The mitochondrial translocator protein single nucleotide polymorphism rs6971 may influence pain and fatigue in rheumatoid arthritis: results of a preliminary study

Nehal Narayan - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Rheumatoid arthritis

N/A

The 21st century rheumatologist: promoting rheumatology to medical students and junior doctors

Martin A Lee - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pan-regional survey of competency of diagnostic knee aspiration skill among GIM speciality trainees

Rehan Asif - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What lay methods of disseminating arthritis research are considered most useful by people with arthritis? A patient and public involvement project

Pola Bieluczyk - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Learning from our students: an exploration of student and teacher experiences in undergraduate rheumatology

Timothy D Reynolds - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Training the next generation of clinical rheumatology researchers: evaluation of a graduate allied health professional and nurse internship programme

David Wright - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Rheumatological conditions in pregnancy: could we make the patient journey more efficient?

Zoe Rutter-Locher - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Certolizumab pegol

A novel human-assisted computer algorithm for identification of hand bones on plain radiographs in psoriatic arthritis

Adwaye M Rambojun - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

N/A

Copyright © 2026. QuantiNova All rights reserved